Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of response (Q57349317)
Jump to navigation
Jump to search
article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of response |
article |
Statements
Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of response (English)
0 references
29 October 2007
0 references
67
0 references
3
0 references
330-334
0 references